Lonza Group AG (0QNO.L)
0QNO.L Stock Price Chart
Explore Lonza Group AG interactive price chart. Choose custom timeframes to analyze 0QNO.L price movements and trends.
0QNO.L Company Profile
Discover essential business fundamentals and corporate details for Lonza Group AG (0QNO.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
7 Mar 2006
Employees
18.00K
Website
https://www.lonza.comCEO
Wolfgang Wienand
Description
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
0QNO.L Financial Timeline
Browse a chronological timeline of Lonza Group AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Jan 2026
Upcoming earnings on 23 Jul 2025
Earnings released on 14 May 2025
EPS came in at CHF 4.14 falling short of the estimated CHF 7.99 by -48.19%, while revenue for the quarter reached CHF 3.52B, missing expectations by -0.28%.
Dividend declared on 13 May 2025
A dividend of CHF 4.00 per share was announced, adjusted to CHF 4.00. The dividend was paid on 15 May 2025.
Earnings released on 25 Jul 2024
EPS came in at CHF 4.61 falling short of the estimated CHF 5.08 by -9.25%, while revenue for the quarter reached CHF 3.06B, beating expectations by +1.84%.
Earnings released on 14 May 2024
EPS came in at CHF 3.36 falling short of the estimated CHF 6.85 by -50.95%, while revenue for the quarter reached CHF 3.64B, beating expectations by +5.96%.
Dividend declared on 13 May 2024
A dividend of CHF 4.00 per share was announced, adjusted to CHF 4.00. The dividend was paid on 15 May 2024.
Earnings released on 30 Jun 2023
EPS came in at CHF 5.52 falling short of the estimated CHF 6.72 by -17.86%, while revenue for the quarter reached CHF 3.08B, missing expectations by -3.08%.
Dividend declared on 9 May 2023
A dividend of CHF 3.50 per share was announced, adjusted to CHF 3.50. The dividend was paid on 11 May 2023.
Earnings released on 31 Dec 2022
EPS came in at CHF 9.73 surpassing the estimated CHF 7.16 by +35.89%, while revenue for the quarter reached CHF 3.24B, beating expectations by +2.01%.
Earnings released on 30 Jun 2022
EPS came in at CHF 6.61 falling short of the estimated CHF 7.30 by -9.45%, while revenue for the quarter reached CHF 2.98B, beating expectations by +0.90%.
Dividend declared on 9 May 2022
A dividend of CHF 3.00 per share was announced, adjusted to CHF 3.00. The dividend was paid on 11 May 2022.
Earnings released on 31 Dec 2021
EPS came in at CHF 35.24 surpassing the estimated CHF 8.00 by +340.50%, while revenue for the quarter reached CHF 2.87B, beating expectations by +8.91%.
Earnings released on 30 Jun 2021
EPS came in at CHF 4.28 falling short of the estimated CHF 4.84 by -11.57%, while revenue for the quarter reached CHF 2.54B, beating expectations by +3.32%.
Dividend declared on 10 May 2021
A dividend of CHF 3.00 per share was announced, adjusted to CHF 3.00. The dividend was paid on 12 May 2021.
Earnings released on 31 Dec 2020
EPS came in at CHF 5.24 falling short of the estimated CHF 6.44 by -18.63%, while revenue for the quarter reached CHF 1.43B, missing expectations by -52.17%.
0QNO.L Stock Performance
Access detailed 0QNO.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.